U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT06875193) titled 'DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes' on Feb. 24.
Brief Summary: Key finding of DM Treatment with combination, A MuLticenter, Randomized, Parallel, Gathering Information of phase 4 Trial to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone add-on to Metformin and DPP-4 inhibitor in Patients with Type 2 Diabetes Who Have Inadequate Glycaemic Control on a Background Combination of Metformin and DPP-4 inhibitor(KLIMT Study)
Study Start Date: May 28, 2024
Study Type: INTERVENTIONAL
Condition:
Type2diabetes
Intervention:
DRUG: DW6012(Dasi...